Literature DB >> 30923875

Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions.

Ezekiel Maloney1, Ramesh S Iyer2, Grace S Phillips2, Shina Menon3, John J Lee4, Michael J Callahan5.   

Abstract

Administration of intravenous contrast media to children is a routine practice at many clinical imaging centers, that can involve special considerations. In this paper, we provide practical information to facilitate optimal performance and oversight of this task. We provide targeted screening questions that can help to identify high-risk pediatric patients for both iodine-based and gadolinium-based intravenous contrast media administration. These include children at risk for allergic-like reactions, thyroid dysfunction, contrast-induced nephropathy, and nephrogenic systemic fibrosis. We make recommendations for addressing "yes" responses to screening questions using risk stratification schema that are specific to children. We also present criteria for selecting children for premedication prior to intravenous contrast administration, and suggest pediatric regimens. Additionally, we discuss practical nuances of intravenous contrast media administration to children and provide a quick-reference table of appropriate treatments with pediatric dosages for adverse contrast reactions.

Entities:  

Keywords:  Adverse reaction; Children; Contrast agent; Gadolinium-based contrast media; Intravenous; Iodine-based contrast media; Prophylaxis; Screening

Mesh:

Substances:

Year:  2019        PMID: 30923875     DOI: 10.1007/s00247-018-4306-6

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  128 in total

1.  Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children.

Authors:  David A Colantonio; Lianna Kyriakopoulou; Man Khun Chan; Caitlin H Daly; Davor Brinc; Allison A Venner; Maria D Pasic; David Armbruster; Khosrow Adeli
Journal:  Clin Chem       Date:  2012-02-27       Impact factor: 8.327

Review 2.  Glomerular filtration rate measurement and estimation in chronic kidney disease.

Authors:  George J Schwartz; Susan L Furth
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

Review 3.  Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review.

Authors:  Martin R Tramèr; Erik von Elm; Pierre Loubeyre; Conrad Hauser
Journal:  BMJ       Date:  2006-07-31

4.  Patterns of intravenous contrast material use and corticosteroid premedication in children--a survey of Society of Chairs of Radiology in Children's Hospitals (SCORCH) member institutions.

Authors:  Andrew T Trout; Jonathan R Dillman; James H Ellis; Richard H Cohan; Peter J Strouse
Journal:  Pediatr Radiol       Date:  2011-05-19

5.  Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults.

Authors:  Jonathan R Dillman; James H Ellis; Richard H Cohan; Peter J Strouse; Sophia C Jan
Journal:  AJR Am J Roentgenol       Date:  2007-12       Impact factor: 3.959

6.  Use of gadolinium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America.

Authors:  Leena B Mithal; Payal S Patel; Divakar Mithal; Hannah L Palac; Michael N Rozenfeld
Journal:  Pediatr Radiol       Date:  2017-03-10

7.  Ascertainment and epidemiology of acute kidney injury varies with definition interpretation.

Authors:  Michael Zappitelli; Chirag R Parikh; Ayse Akcan-Arikan; Kimberley K Washburn; Brady S Moffett; Stuart L Goldstein
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 8.237

Review 8.  Measurement and estimation of GFR in children and adolescents.

Authors:  George J Schwartz; Dana F Work
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 8.237

9.  Incidence and severity of acute allergic-like reactions to i.v. nonionic iodinated contrast material in children.

Authors:  Jonathan R Dillman; Peter J Strouse; James H Ellis; Richard H Cohan; Sophia C Jan
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

10.  Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban children's hospital--retrospective analysis of data in 12,494 patients.

Authors:  Michael J Callahan; Linda Poznauskis; David Zurakowski; George A Taylor
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

View more
  5 in total

Review 1.  Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know.

Authors:  Rama S Ayyala; Sudha A Anupindi; Michael S Gee; Andrew T Trout; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2019-07-26

2.  2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction.

Authors:  Tomasz Bednarczuk; Thomas H Brix; Wolfgang Schima; Georg Zettinig; George J Kahaly
Journal:  Eur Thyroid J       Date:  2021-06-16

Review 3.  Safety considerations related to intravenous contrast agents in pediatric imaging.

Authors:  Safia H E Cheeney; Ezekiel Maloney; Ramesh S Iyer
Journal:  Pediatr Radiol       Date:  2022-08-09

Review 4.  Gadolinium retention: should pediatric radiologists be concerned, and how to frame conversations with families.

Authors:  Sakura M Noda; Murat Alp Oztek; A Luana Stanescu; Ezekiel Maloney; Dennis W W Shaw; Ramesh S Iyer
Journal:  Pediatr Radiol       Date:  2021-05-12

5.  Assessment of the Membranous Labyrinth in Infants Using a Heavily T2-weighted 3D FLAIR Sequence without Contrast Agent Administration.

Authors:  G Conte; S Casale; L Caschera; F M Lo Russo; C Paolella; C Cinnante; F Di Berardino; D Zanetti; D Stocchetti; E Scola; L Bassi; F Triulzi
Journal:  AJNR Am J Neuroradiol       Date:  2021-01-28       Impact factor: 3.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.